Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.
Spiral Therapeutics has raised $27.0M in total funding. The most recent round was Series B. The last funding was announced in April 2026.
Spiral Therapeutics's investors include Catalio Capital Management, Inveready, Camden Partners, Advanced Bionics, Humboldt Fund.
Spiral Therapeutics is headquartered in San Francisco, United States.
Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for inner ear disorders.
Spiral Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spiral Therapeutics — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/spiral-therapeutics. Accessed July 31, 2026.
VCBacked. (2026). Spiral Therapeutics — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/spiral-therapeutics
{{cite web |title=Spiral Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/spiral-therapeutics |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated